Table 1 Demographics of study group
From: Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19
|  | N | Age (mean ± SD) | Age (yrs, range) |    Sex | PMI (hrs, mean ± SD) | |
|---|---|---|---|---|---|---|
M | F | |||||
Controls | 16 | 71.8 ± 8.6 | 55–84 | 7 | 9 | 68.3 ± 87.0 |
      Healthy control | 9 | 72.8 ± 7.5 | 59–80 | 4 | 5 | 52.1 ± 24.3 |
       Neurological control | 7 | 70.6 ± 10.5 | 55–84 | 3 | 4 | 89.1 ± 131.2 |
COVID19 + ​ | 22 | 74.8 ± 12.1 | 51–89 | 13 | 9 | 43.9 ± 25.2 |
Lewy body disease | 6 | 78.7 ± 6.7 | 72–90 | 6 | 0 | 104.0 ± 111.2 |
Alzheimer disease | 3 | 69.7 ± 15.3 | 52–78 | 1 | 2 | 56.0 ± 55.4 |
Other neurodegenerative disease | 3 | 78.0 ± 3.6 | 74–79 | 3 | 0 | 112.0 ± 113.4 |